DK1458413T3 - Pharmaceutical compositions on the b asis of azetidine derivatives - Google Patents

Pharmaceutical compositions on the b asis of azetidine derivatives

Info

Publication number
DK1458413T3
DK1458413T3 DK02801165T DK02801165T DK1458413T3 DK 1458413 T3 DK1458413 T3 DK 1458413T3 DK 02801165 T DK02801165 T DK 02801165T DK 02801165 T DK02801165 T DK 02801165T DK 1458413 T3 DK1458413 T3 DK 1458413T3
Authority
DK
Denmark
Prior art keywords
asis
pharmaceutical compositions
azetidine derivatives
azetidine
derivatives
Prior art date
Application number
DK02801165T
Other languages
Danish (da)
Inventor
Maria-Teresa Peracchia
Valerie Bobineau
Sophie Cote
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1458413T3 publication Critical patent/DK1458413T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK02801165T 2001-12-21 2002-12-20 Pharmaceutical compositions on the b asis of azetidine derivatives DK1458413T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116638A FR2833842B1 (en) 2001-12-21 2001-12-21 PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES
PCT/FR2002/004514 WO2003053431A2 (en) 2001-12-21 2002-12-20 Pharmaceutical compositions based on azetidine derivatives

Publications (1)

Publication Number Publication Date
DK1458413T3 true DK1458413T3 (en) 2009-11-23

Family

ID=8870824

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02801165T DK1458413T3 (en) 2001-12-21 2002-12-20 Pharmaceutical compositions on the b asis of azetidine derivatives

Country Status (32)

Country Link
EP (1) EP1458413B1 (en)
JP (1) JP5021887B2 (en)
KR (1) KR20040068308A (en)
CN (1) CN100388918C (en)
AP (1) AP1754A (en)
AR (1) AR037687A1 (en)
AU (1) AU2002364866B2 (en)
BR (1) BR0215048A (en)
CA (1) CA2470443A1 (en)
CO (1) CO5590911A2 (en)
DE (1) DE60233071D1 (en)
DK (1) DK1458413T3 (en)
EA (1) EA006510B1 (en)
EC (1) ECSP045162A (en)
FR (1) FR2833842B1 (en)
HK (1) HK1070840A1 (en)
HR (1) HRP20040575A2 (en)
HU (1) HUP0402586A3 (en)
IL (1) IL162563A0 (en)
MA (1) MA27086A1 (en)
ME (1) MEP16608A (en)
MX (1) MXPA04005558A (en)
MY (1) MY138172A (en)
NO (1) NO20042781L (en)
NZ (1) NZ533225A (en)
OA (1) OA12750A (en)
PL (1) PL203248B1 (en)
RS (1) RS55504A (en)
TW (1) TWI256304B (en)
UA (1) UA77736C2 (en)
WO (1) WO2003053431A2 (en)
ZA (1) ZA200404338B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498123A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Emulsifying systems containing azetidine derivatives
EP1498122A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid systems containing azetidine derivatives
BRPI0507801A (en) 2004-02-17 2007-07-10 Esteve Labor Dr substituted azetidine compounds, process for preparing substituted azetidine compounds, medicament and use of at least one substituted azetidine compound
FR2879932B1 (en) * 2004-12-27 2007-03-23 Aventis Pharma Sa FORMULATIONS INJECTABLE OR ORALLY ADMINISTRATIVE OF AZETIDINE DERIVATIVES
BRPI0613505A2 (en) 2005-06-30 2011-01-11 Prosidion Ltd gpcr agonists
DK2114933T3 (en) 2007-01-04 2012-01-02 Prosidion Ltd Piperidine GPCR agonists
GB0700122D0 (en) 2007-01-04 2007-02-14 Prosidion Ltd GPCR agonists
AR064736A1 (en) 2007-01-04 2009-04-22 Prosidion Ltd GPCR AGONISTS
WO2008081208A1 (en) 2007-01-04 2008-07-10 Prosidion Limited Piperidine gpcr agonists
AR064735A1 (en) 2007-01-04 2009-04-22 Prosidion Ltd GPCR AGONISTS AND PHARMACEUTICAL COMPOSITION BASED ON THE COMPOUND
GB0720390D0 (en) 2007-10-18 2007-11-28 Prosidion Ltd G-Protein coupled receptor agonists
GB0720389D0 (en) 2007-10-18 2008-11-12 Prosidion Ltd G-Protein Coupled Receptor Agonists
FR2923719B1 (en) * 2007-11-15 2009-11-20 Sanofi Aventis PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES
FR2928149B1 (en) 2008-02-29 2011-01-14 Sanofi Aventis AZETIDINE-DERIVED COMPOUNDS, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2946650B1 (en) * 2009-06-16 2011-08-19 Sanofi Aventis ESTERS DERIVED FROM AZETIDINES, THEIR PREPARATION AND THEIR USE IN THERAPEUTICS.
UA153183U (en) 2022-10-27 2023-05-31 Андрій Валерійович Максимов GLASS FOR DRINK PREPARATION

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR73668B (en) * 1978-11-21 1984-03-28 Hoffmann La Roche
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
HRP980026A2 (en) * 1998-01-20 1999-10-31 Pliva Pharm & Chem Works 1-izothiazolydinone derivatives of azetidine-2-ones, processes for the preparation and use thereof
DE1015046T1 (en) * 1998-07-14 2001-02-08 Em Industries, Inc. MICRODISPERSION ADMINISTRATION SYSTEM FOR MEDICINAL PRODUCTS
FR2783246B1 (en) * 1998-09-11 2000-11-17 Aventis Pharma Sa AZETIDINE DERIVATIVES, THEIR PREPARATION AND THE MEDICINES CONTAINING THEM
FR2805818B1 (en) * 2000-03-03 2002-04-26 Aventis Pharma Sa AZETIDINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2805817B1 (en) * 2000-03-03 2002-04-26 Aventis Pharma Sa PHARMACEUTICAL COMPOSITIONS CONTAINING AZETIDINE DERIVATIVES, NOVEL AZETIDINE DERIVATIVES AND THEIR PREPARATION
FR2805810B1 (en) * 2000-03-03 2002-04-26 Aventis Pharma Sa PHARMACEUTICAL COMPOSITIONS CONTAINING 3- AMINO-AZETIDINE DERIVATIVES, THE NEW DERIVATIVES AND THEIR PREPARATION
FR2814678B1 (en) * 2000-10-04 2002-12-20 Aventis Pharma Sa COMBINATION OF AN ANTAGONIST OF THE CB1 RECEPTOR AND SIBUTRAMINE, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE TREATMENT OF OBESITY

Also Published As

Publication number Publication date
AU2002364866A1 (en) 2003-07-09
DE60233071D1 (en) 2009-09-03
UA77736C2 (en) 2007-01-15
HK1070840A1 (en) 2005-06-30
JP2005516945A (en) 2005-06-09
CN100388918C (en) 2008-05-21
MXPA04005558A (en) 2004-12-06
AP2004003066A0 (en) 2004-06-30
NO20042781L (en) 2004-09-20
PL203248B1 (en) 2009-09-30
FR2833842B1 (en) 2004-02-13
AU2002364866B2 (en) 2006-11-30
WO2003053431A3 (en) 2003-12-18
MY138172A (en) 2009-04-30
PL372708A1 (en) 2005-07-25
CA2470443A1 (en) 2003-07-03
AR037687A1 (en) 2004-12-01
JP5021887B2 (en) 2012-09-12
CO5590911A2 (en) 2005-12-30
ZA200404338B (en) 2005-06-02
EA200400843A1 (en) 2004-12-30
NZ533225A (en) 2007-02-23
IL162563A0 (en) 2005-11-20
HUP0402586A2 (en) 2005-03-29
ECSP045162A (en) 2004-08-27
HRP20040575A2 (en) 2004-10-31
AP1754A (en) 2007-07-18
WO2003053431A2 (en) 2003-07-03
BR0215048A (en) 2004-11-03
OA12750A (en) 2006-07-03
HUP0402586A3 (en) 2011-05-30
EP1458413B1 (en) 2009-07-22
FR2833842A1 (en) 2003-06-27
MA27086A1 (en) 2004-12-20
TW200301108A (en) 2003-07-01
EP1458413A2 (en) 2004-09-22
MEP16608A (en) 2010-06-10
KR20040068308A (en) 2004-07-30
EA006510B1 (en) 2005-12-29
CN1602206A (en) 2005-03-30
TWI256304B (en) 2006-06-11
RS55504A (en) 2007-06-04

Similar Documents

Publication Publication Date Title
FI20011478A (en) Pharmaceutical composition
AR028204A1 (en) ELECTRO-THREADED PHARMACEUTICAL COMPOSITIONS
FI20001750A (en) Pharmaceutical compositions
ITMI20010748A0 (en) PHARMACEUTICAL COMPOSITIONS
NO20033556L (en) Pharmaceutical Formulations
NO20033384D0 (en) Pharmaceutical formulation
PT1242087E (en) PHARMACEUTICAL COMPOSITIONS
DK1397364T3 (en) Newly disclosed pyrrole derivatives as pharmaceutical agents
DK1443992T3 (en) Collapsible syringe insert
EE200300416A (en) Pharmaceutical form
FI20010780A0 (en) Improved compositions
DE60109207D1 (en) ORAL COMPOSITION
DK1395242T3 (en) Liquid pharmaceutical composition
EE05020B1 (en) The pharmaceutical composition of G1buride
PT1467724E (en) AGOMELATIN ORODISPERSAVEL PHARMACEUTICAL COMPOSITION
IS7051A (en) pharmaceutical compositions
DK1458413T3 (en) Pharmaceutical compositions on the b asis of azetidine derivatives
NO20040860L (en) Pharmaceutical composition including lumiracoxib
FI20022128A0 (en) Pharmaceutical composition
PT1239832E (en) PHARMACEUTICAL COMPOSITIONS
NO20034556D0 (en) Imidazotriazinone-containing compositions for nasal administration
NO20031095L (en) Pharmaceutical compositions
DK1475379T3 (en) Use of scopin ester derivatives for the manufacture of drugs
EE200300465A (en) Pharmaceutical compositions based on pyridoindolone derivatives
NO20020524D0 (en) Stabilized Organic-Peroxide Compositions